preparation and application of 3-bromo-2-fluorobenzonitrile_industrial additives

background and overview^[1]

3-bromo-2-fluorobenzonitrile is an organic intermediate that can be prepared from 3-bromo-2-fluorobenzoic acid in two steps. 3-bromo-2-fluorobenzonitrile can be used as a pharmaceutical intermediate for the preparation of stk4 inhibitors.

preparation^[1]

step 1, preparation of 3-bromo-2-fluorobenzamide (2-80)

3-bromo-2-fluorobenzoic acid (2-79, mg, 1.83 mmol) and socl₂ (4.39 mg, 3.66 mmol) in dcm (5 ml) at room temperature the mixture was stirred for 1 h, and then ammonia water (1 ml) was added. the resulting mixture was then stirred at room temperature for 2 h. after the reaction was completed, the resulting mixture was washed with water and extracted with ethyl acetate (150 ml × 3). the combined organic phases were concentrated under reduced pressure, and the resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate = 1/1) to obtain intermediate 2-80 (white solid, 300 mg, 75% yield ). lcms (m/z): 218 [m+h]⁺.

step 2, preparation of 3-bromo-2-fluorobenzonitrile (2-81)

3-bromo-2-fluorobenzamide (2-80, 260 mg, 1.2 mmol), tfaa (471 mg, 2.4 mmol) and pyridine (py) (474 ​​mg, 6.0 mmol) were dissolved in diox the mixture in alkane (5 ml) was stirred at room temperature for 4 h. after the reaction was completed, the resulting mixture was washed with water and extracted with ethyl acetate (150 ml × 3). the combined organic phases were concentrated under reduced pressure, and the resulting residue was purified by silica gel chromatography (petroleum ether/ethyl acetate = 1/1) to obtain intermediate 2-81 (white solid, 100 mg, 42% yield).

apply^[1]

3-bromo-2-fluorobenzonitrile can be used to prepare 3-(6-amino-5-(1-oxo-1,2,3,4-tetrahydroisoquinolin-6-yl)pyridine- 3-yl)-2-fluorobenzonitrile (i-34). i-34 is an inhibitor of stk4 (also known as mst1), a serine-threonine kinase that is part of the hippo signaling pathway. stk4 is involved in multiple cellular processes, including proliferation, transport, apoptosis, immune response, and stress response.

references

[1] from pct int. appl., 2016161145, 06 oct 2016